BridgeBio Revenue and Competitors

Location

#2447

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • BridgeBio's estimated annual revenue is currently $57M per year.(i)
  • BridgeBio's estimated revenue per employee is $81,010
  • BridgeBio's total funding is $434M.
  • BridgeBio's current valuation is $1.9B. (January 2022)

Employee Data

  • BridgeBio has 703 Employees.(i)
  • BridgeBio grew their employee count by 27% last year.

BridgeBio's People

NameTitleEmail/Phone
1
Chief Staff to the CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief People OfficerReveal Email/Phone
4
Chief Regulatory Affairs OfficerReveal Email/Phone
5
Chief Operating Officer (Eidos Therapeutics & Calcilytix Therapeutics)Reveal Email/Phone
6
Chief Legal OfficerReveal Email/Phone
7
CEO and FounderReveal Email/Phone
8
Chief Staff to the President & COOReveal Email/Phone
9
Chief Medical Affairs OfficerReveal Email/Phone
10
Chief Regulatory Officer & EVP Portfolio Strategy and ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is BridgeBio?

We focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. Our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting R&D with expert capabilities and placing them in a value maximizing corporate structure.

keywords:Biotechnology

$434M

Total Funding

703

Number of Employees

$57M

Revenue (est)

27%

Employee Growth %

$1.9B

Valuation

N/A

Accelerator

BridgeBio News

2022-04-20 - How a surprise finding made an Alnylam study one of ...

BridgeBio Pharma, a young biotech trying to bring its first drug to market, followed the blueprint of one of the world's largest...

2022-04-17 - BridgeBio Pharma (BBIO) Gains As Market Dips: What You Should Know

Over the past month, the Zacks Consensus EPS estimate remained stagnant. BridgeBio Pharma is holding a Zacks Rank of #3 (Hold) right now. The...

2022-03-22 - BridgeBio Pharma to Present Updated Results from Phase 2 ...

About BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$100.8M7067%N/A
#2
$134.4M7234%$881M
#3
$274.1M72556%N/A
#4
$137.2M7263%$1.1B
#5
$166.8M73115%N/A